Keyword: Biotechnology

News

Biosimilar Remicade Accepted for EU Drug Review

13.04.2012 - Europe's drugs watchdog is to evaluate a copycat version of the best-selling biotech drug Remicade, used to treat arthritis, in a move that underscores how the market for so-called...

News

Amgen, Astra to Collaborate on Several Drugs

03.04.2012 - Amgen and British drugmaker AstraZeneca announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline...

News

German Farm Group Regrets BASF's GMO Move To U.S.

20.01.2012 - Germany's giant association of farming cooperatives said it regretted the decision by BASF to transfer its research into crops with genetically modified organisms (GMOs) from...

News

India's Piramal to Boost Financial Business

22.11.2011 - Diversified Indian conglomerate Piramal Group plans to lend up to $193 million to real estate projects in the current fiscal year to March as it focuses on building its newly...

News

Innovation Expected from API Manufacturers

20.10.2011 - Up To Task - Facing a huge patent cliff and a less-than-robust pipeline, pharma companies must look to customized and personalized medicines. This is where API manufacturers are...

Chemistry & Life Sciences

White Biotechnology as an Innovation Platform for the Chemical Industry

07.09.2011 - Key Platform - White biotechnology is establishing itself as a key technology platform for innovative and sustainable processes and products in the chemical industry. In cases...

Plant Construction & Process Technology

NNE Pharmaplan Extends International Business with A New Structure

06.09.2011 - Leading The Way - With sales of around €200 million in 2010, NNE Pharmaplan is one of the world's leading engineering and consulting companies for the pharmaceutical and...

News

Synthes H1 Profit Rises

10.08.2011 - Synthes posted higher six-month net earnings of $454.37 million compared with $424.59 million last year. Half-yearly earnings per share improved to €3.83 from €3.58 a year earlier...